Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Multimodal Analgesia in Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Rush University Medical Center
- Registration Number
- NCT03586934
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT03579446
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
- Conditions
- Interventions
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 62
- Registration Number
- NCT03574792
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
QLB After Nephrectomy
- Conditions
- Interventions
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Medical University of Lublin
- Target Recruit Count
- 105
- Registration Number
- NCT03529201
- Locations
- 🇵🇱
Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów, Rzeszów, Poland
🇵🇱Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok, Białystok, Poland
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Conditions
- Interventions
- Drug: Tranexamic acid (TXA)Drug: HydrocodoneDrug: labetalolDrug: metforminDrug: nifedipineDrug: oxycodoneDrug: clindamycinDrug: azithromycinDrug: escitalopramDrug: sertralineDrug: CiprofloxacinDrug: ondansetronDrug: DoxycyclineDrug: LevofloxacinDrug: MethylphenidateDrug: CitalopramDrug: SumatriptanDrug: CyclobenzaprineDrug: FurosemideDrug: RosuvastatinDrug: GabapentinDrug: HydrochlorothiazideDrug: HydroxyureaDrug: TrazodoneDrug: TopiramateDrug: ValganciclovirDrug: RemdesivirDrug: VenlafaxineDrug: VerapamilDrug: FluvoxamineDrug: AnakinraDrug: TocilizumabDrug: AmoxicillinDrug: BupropionDrug: BuprenorphineDrug: LevetiracetamDrug: ParoxetineDrug: Duloxetine
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Duke University
- Target Recruit Count
- 1600
- Registration Number
- NCT03511118
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Loma Linda University Health, Loma Linda, California, United States
PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Senthil Sadhasivam
- Target Recruit Count
- 500
- Registration Number
- NCT03495388
- Locations
- 🇺🇸
UPMC Children's Hospital, Pittsburgh, Pennsylvania, United States
Opioid Analgesics for Acute Fracture Pain in Adults Discharged From the ED
- Conditions
- Interventions
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 5
- Registration Number
- NCT03478423
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
- Conditions
- Interventions
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Study Investigator-Sponsor
- Target Recruit Count
- 156
- Registration Number
- NCT03480009
- Locations
- 🇺🇸
Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Planned Parenthood of Western Pennsylvania, Pittsburgh, Pennsylvania, United States
Nasal Human Abuse Potential of PTI-821
- Conditions
- Interventions
- First Posted Date
- 2018-03-23
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 38
- Registration Number
- NCT03475862
- Locations
- 🇺🇸
PRA-EDS, Salt Lake City, Utah, United States
Impact of Tramadol and Oxycodone on Sleep Apnea
- First Posted Date
- 2018-03-05
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Target Recruit Count
- 60
- Registration Number
- NCT03454217
- Locations
- 🇨🇭
Lausanne University Hospital, Lausanne, Vaud, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.